NEURACEQ 300 MBq/ml sol inj 300 MBq 1 pce
7680662100015
CH-66210
V09AX06
17.01.1.
Reimbursement limitations:
GLIVECGIST
Traitement des tumeurs stromales gastro-intestinales (GIST) malignes non résécables et/ou métastatiques chez l'adulte. Traitement adjuvant …
1 / 2
google
Details
- GTIN
- 7680662100015
- Pharmacode
- -
- Product number
- 6621001
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- florbetabenum(18-F) 300 MBq, acidum ascorbicum, ethanolum anhydricum 118 mg, macrogolum 400, natrii ascorbas corresp. natrium 3.34 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Neuraceq 300 MBq/ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
florbetabenum(18-F)
|
300.0 MBQ | Substance | Wirkstoff (Principe actif) |
|
acidum ascorbicum
|
- | Substance | HNIDK |
|
ethanolum anhydricum
|
118.0 MG | Substance | HBESI |
|
macrogolum 400
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
natrii ascorbas
|
- | Substance | HNIDK |
|
natrium
|
3.34 MG | Substance | HBESI |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
SWAN Isotopen AG
3010 Bern
Authorization information
- Swissmedic authorization number
- 66210
- Drug name
- Neuraceq, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- V09AX06
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 23/08/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 17.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NEURACEQ 300 MBq/ml sol inj 300 MBq 1 pce
- Description (DE)
- NEURACEQ 300 MBq/ml Inj Lös 300 MBq 1 Stk
- Market launch
- 23/08/2017
- Narcotic (BTM)
- No